Shire Pharmaceuticals

Pan-European launch concepts for Intuniv, a new ADHD medication developed for children and teenagers. The concepts received very positive reactions in focus groups of GPs and HCPs across Europe.


This was about the mundanities of everyday life, which for parents of a child with ADHD a humdrum, uneventful life is what they dream of.

Another element of the brief was to devise DM, targeting GPs at back-to-school time, a time when young ADHD patients are particularly stressed after the long summer break and settled routine. 

The launch was a great success, as was the medication and it is now widely prescribed.